PotentiaMetrics reaches a major milestone by partnering with its first national US health plan, offering a MyCancerJourney advocacy solution as a benefit to self-insured employers. This marked the beginning of PotentiaMetrics integration into the health plan market, as more employers recognized the value of supporting their employees with personalized cancer support. Also, In 2022, PotentiaMetrics was approached by a national provider of dialysis care to develop an outcomes tool specifically for individuals with End-Stage Renal Disease (ESRD). We successfully created and tested the tool, informing providers which patients are the best candidates for home care.